by mediaid pharmacy | Jan 22, 2026 | Blogs
Ponatinix 15 mg (Ponatinib) is a third-generation tyrosine kinase inhibitor (TKI) widely prescribed in oncology for resistant or relapsed chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). What Is Ponatinix 15...
by mediaid pharmacy | Jan 22, 2026 | Blogs
Osimertinib (Tagrix) 40mg & 80mg is a next-generation targeted therapy widely prescribed in oncology for the treatment of EGFR-mutated non-small cell lung cancer (NSCLC). As a third-generation EGFR tyrosine kinase inhibitor (TKI), Osimertinib is clinically proven...
by mediaid pharmacy | Jan 21, 2026 | Blogs
Olanib 50 mg is an oral anti-cancer medicine containing Olaparib INN, a PARP inhibitor widely used in targeted oncology therapy. It is prescribed mainly for BRCA-mutated cancers and selected solid tumors under specialist supervision. What Is Olanib Tablet 50mg? Olanib...
by mediaid pharmacy | Jan 17, 2026 | Blogs
Cancer treatment decisions are rarely simple especially when patients and caregivers are navigating complex diagnoses like ovarian or breast cancer. Alongside emotional stress, there’s often confusion around which medicines work best, how targeted therapies differ...
by mediaid pharmacy | Jan 17, 2026 | Blogs
Breast cancer treatment has evolved rapidly over the last decade, especially with the introduction of targeted therapies that focus on specific cancer-driving mechanisms rather than broadly attacking healthy cells. For patients diagnosed with HER2-positive breast...
by mediaid pharmacy | Jan 9, 2026 | Blogs
Obetix 5 mg (Obeticholic Acid) is a prescription medication widely used in the management of primary biliary cholangitis (PBC), a chronic autoimmune liver disease that can progress to liver failure if left untreated. Obetix works by activating the farnesoid X receptor...
